Processa Pharmaceuticals (PCSA) | 2014 | 1,796,566.67% |
Benitec Biopharma Ltd ADR (BNTC) | 2014 | 72,037.53% |
Xenetic Biosciences (XBIO) | 2014 | 65,893.6% |
Tempest Therapeutics (TPST) | 2014 | 384.34% |
Agios Pharm (AGIO) | 2014 | 371.15% |
TG Therapeutics (TGTX) | 2014 | 300% |
Amicus Therapeutics (FOLD) | 2014 | 254.04% |
PTC Therapeutics (PTCT) | 2014 | 209.44% |
Esperion Therapeutics (ESPR) | 2014 | 192.83% |
Atara Biotherapeutics (ATRA) | 2014 | 170.48% |
Skye Bioscience, Inc Common Stock (SKYE) | 2014 | 158.33% |
Fennec Pharmaceuticals (FENC) | 2014 | 149.07% |
Neurocrine Biosciences (NBIX) | 2014 | 140.99% |
Immunic (IMUX) | 2014 | 103.51% |
iBio, Inc Common Stock (IBIO) | 2014 | 97.14% |
Xenon Pharmaceuticals (XENE) | 2014 | 97.11% |
Arbutus Biopharma (ABUS) | 2014 | 90.57% |
Enanta Pharmaceuticals (ENTA) | 2014 | 85.65% |
Puma Biotechnology (PBYI) | 2014 | 83.95% |
Lexaria Bioscience (LEXX) | 2014 | 75.62% |
PharmaCyte Biotech (PMCB) | 2014 | 71.92% |
Xencor (XNCR) | 2014 | 70.82% |
Travere Therapeutics (TVTX) | 2014 | 70.24% |
Myriad Genetics (MYGN) | 2014 | 62.81% |
BioCryst Pharmaceuticals (BCRX) | 2014 | 61.06% |
